Ingevity (NGVT) Research & Development (2016 - 2026)

Ingevity (NGVT) has 11 years of Research & Development data on file, last reported at $6.7 million in Q1 2026.

• Research & Development for Q1 2026 came in at $6.7 million, down 4.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.9 million (up 7.04% YoY), and the FY2025 annual result was $28.4 million, up 15.92% from the prior year.
• Research & Development slipped to $6.7 million in Q1 2026 per NGVT's latest filing, from $7.4 million in the prior quarter.
• Over five years, Research & Development peaked at $8.8 million in Q1 2023 and troughed at $800000.0 in Q4 2023.
• A 5-year average of $7.0 million and a median of $7.3 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2024: Research & Development slumped 88.89% in 2023, then soared 712.5% in 2024.
• A 5-year view of Research & Development shows it stood at $7.2 million in 2022, then tumbled by 88.89% to $800000.0 in 2023, then soared by 712.5% to $6.5 million in 2024, then climbed by 13.85% to $7.4 million in 2025, then retreated by 9.46% to $6.7 million in 2026.
• Business Quant data shows NGVT's Research & Development at $6.7 million in Q1 2026, $7.4 million in Q4 2025, and $7.0 million in Q3 2025.